Zyla Life Sciences Business Combination, Contingent Consideration, Liability, Current
Zyla Life Sciences had Business Combination, Contingent Consideration, Liability, Current of $5.83 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2020-05-14
- 2020-03-31: Business Combination, Contingent Consideration, Liability, Current $5.83M.
- 2019-12-31: Business Combination, Contingent Consideration, Liability, Current $3.50M.
- 2019-09-30: Business Combination, Contingent Consideration, Liability, Current $2.70M.
- 2019-06-30: Business Combination, Contingent Consideration, Liability, Current $2.50M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2020-03-31 | $5.83M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $3.50M 10-Q · filed 2020-05-14 |
| 2019-09-30 | $2.70M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.50M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.20M 10-Q · filed 2019-05-17 |
| 2019-02-01 | $1.20M 10-Q · filed 2020-05-14 |
| 2019-01-31 | $1.20M 10-Q · filed 2019-08-13 |